Cover Image
市場調查報告書

全球創傷用生技藥品市場:2016∼2020年

Global Wound Biologics Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 351694
出版日期 內容資訊 英文 54 Pages
訂單完成後即時交付
價格
Back to Top
全球創傷用生技藥品市場:2016∼2020年 Global Wound Biologics Market 2016-2020
出版日期: 2016年02月03日 內容資訊: 英文 54 Pages
簡介

生技藥品的傷口護理流程,應用具有抗菌,抗氧化,抗發炎特性的植物來源活性生物分子等生物藥品再構成本來的修復機制。全球創傷用生技藥品市場,預計2016∼2020年以年複合成長率20.63%擴大。

本報告提供全球創傷用生技藥品市場相關調查,創傷用生技藥品概要,市場趨勢與到2020年的預測,市場課題,主要供應商趨勢與主要供應商所面臨的市場機會和威脅等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 各產品市場區隔

  • 各皮膚替代
  • 各生長因子

第7章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第8章 推動市場的要素

第9章 促進要素的影響

第10章 市場課題

  • 受限的臨床資料的取得性
  • 替代物的取得性
  • 嚴厲的法律規章認證流程

第11章 促進要素與課題的影響

第12章 市場趨勢

  • 技術的進步
  • 開發中產品的增加
  • 並用敷料的需求
  • 新治療方法的登場

第13章 供應商環境

  • 競爭模式
  • 主要消息
  • 合併、收購
  • 市場佔有率分析:2015年
  • Smith & Nephew
  • Organogenesis
  • Acelity
  • Integra LifeSciences
  • 其他值得注意的供應商

第14章 附錄

第15章 關於Technavio

圖表

目錄
Product Code: IRTNTR8401

About Wound Biologics

Mechanical, chemical, thermal, and radiogenic damages can cause cuts, tears, and punctures in the skin, blood vessels, nerves, muscles, internal organs, bones, and joints. Wounds are of two types: acute and chronic. The reparative process in acute wounds occurs at a predictable and expected rate leading to faster healing, while it fails to occur in a predictable amount of time in chronic wounds.

Biologic wound healing process helps re-establish the innate repair mechanisms and may involve the application of biological agents such as plant-derived active biomolecules having antimicrobial, antioxidant, and anti-inflammatory attributes. Biologic dressings prevent evaporative water loss, protein and electrolyte loss, heat loss, and wound contamination. Wound biologics such as granular wound beds permit autolytic debridement for the healing process.

Technavio's analysts forecast the global wound biologics market to grow at a CAGR of 20.63% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global wound biologics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of:

  • Skin substitutes
  • Growth factors

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Wound Biologics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Acelity
  • Integra LifeSciences
  • Organogenesis
  • Smith & Nephew

Other Prominent Vendors

  • Avita Medical
  • BioDlogics
  • ConvaTec
  • Cytori Therapeutics
  • Intercytex
  • MacroCure
  • Molyncke Health Care
  • Nuo Therapeutics
  • Osiris Therapeutics
  • Regenerys

Market driver

  • Prevalence of chronic diseases
  • For a full, detailed list, view our report

Market challenge

  • Limited availability of clinical data
  • For a full, detailed list, view our report

Market trend

  • Advances in technology
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Global wound biologics market by skin substitutes
  • Global wound biologics market by growth factors

PART 07: Geographical segmentation

  • Wound biologics market in Americas
  • Wound biologics market in EMEA
  • Wound biologics market in APAC

PART 08: Market drivers

  • Prevalence of chronic diseases
  • Availability of different skin substitutes
  • Rise in geriatric population

PART 09: Impact of drivers

PART 10: Market challenges

  • Limited availability of clinical data
  • Availability of alternatives
  • Stringent regulatory approval process

PART 11: Impact of drivers and challenges

PART 12: Market trends

  • Advances in technology
  • Increase in pipeline products
  • Demand for combination dressings
  • Emergence of new treatment options

PART 13: Vendor landscape

  • Competitive scenario
  • Key news
  • Mergers and acquisitions
  • Market share analysis 2015
  • Smith & Nephew
  • Organogenesis
  • Acelity
  • Integra LifeSciences
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

PART 15: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Stages of wound healing
  • Exhibit 03: Types of wounds
  • Exhibit 04: Global wound biologics market 2015-2020 ($ billions)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Global wound biologics market segmentation by product
  • Exhibit 07: Global wound biologics market by skin substitutes 2015-2020 ($ millions)
  • Exhibit 08: Growth factors involved in wound healing
  • Exhibit 09: Global wound biologics market by growth factors 2015-2020 ($ millions)
  • Exhibit 10: Global wound biologics market segmentation by geography 2015
  • Exhibit 11: Wound biologics market in Americas 2015-2020 ($ millions)
  • Exhibit 12: Wound biologics market in EMEA 2015-2020 ($ millions)
  • Exhibit 13: Wound biologics market in APAC 2015-2020 ($ millions)
  • Exhibit 14: Global wound biologics market segmentation by geography 2015-2020 ($ millions)
  • Exhibit 15: Global wound biologics market segmentation by geography 2015-2020
  • Exhibit 16: Different commercially available skin substitutes
  • Exhibit 17: Impact of drivers
  • Exhibit 18: Impact of drivers and challenges
  • Exhibit 19: Middle- and late-stage wound biologics in pipeline
  • Exhibit 20: Ranking of vendors 2015
  • Exhibit 21: Market share of vendors 2015
  • Exhibit 22: Smith & Nephew: Business segmentation by revenue 2014
  • Exhibit 23: Smith & Nephew: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 24: Smith & Nephew: Key takeaways
  • Exhibit 25: Organogenesis: Key takeaways
  • Exhibit 26: Acelity: Business segmentation by revenue 2014
  • Exhibit 27: Acelity: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 28: Acelity: Key takeaways
  • Exhibit 29: Integra LifeSciences: Key takeaways
Back to Top